TABLE 3:
Randomized Placebo-Controlled Trials in Pediatric Anxiety Disorders
| Class | Reference | Disorder | N | Results |
|---|---|---|---|---|
| 5-HT1A modulator | Strawn et al, 2017 | GAD | 227 | Buspirone = placebo |
| Strawn et al, 2017 | GAD | 341 | Buspirone = placebo | |
| SSRI | RUPP, 2001 | Mixed anxiety disorders | 124 | Fluvoxamine > placebo |
| Strawn et al, 2019 | GAD | 51 | Escitalopram > placebo | |
| Rynn et al, 2001 | GAD | 22 | Sertraline > placebo | |
| Black and Uhde, 1994 | Selective mutism, SoAD, Avoidant Disorder | 15 | Fluoxetine > placebo | |
| Wagner et al, 2004 | SoAD | 322 | Paroxetine > placebo | |
| Beidel et al, 200* | SoAD | 122 | SET-C > fluoxetine > placebo | |
| Walkup et al, 2008 | Mixed anxiety disorders | 488 | CBT = sertraline > placebo CBT+sertraline > sertraline/ CBT CBT+sertraline > placebo |
|
| Birmaher et al, 2003 | Mixed anxiety disorders | 74 | Fluoxetine > placebo | |
| SNRI | Rynn et al, 2007 | GAD | 153 160 |
Venlafaxine ER > placebo |
| Strawn et al, 2015 | GAD | 272 | Duloxetine > placebo | |
| March et al, 200* | SoAD | 293 | Venlafaxine > placebo | |
| Geller et al, 2007 | Mixed anxiety disorders + ADHD | 176 | Atomoxetine > placebo | |
| TCA | Gittleman-Klein & Klein, 1971 | SoAD and mixed anxiety | 35 | Imipramine > placebo |
| Berney et al, 1981 | School refusal | 51 | Clomipramine = placebo | |
| Klein et al, 1992 | Separation anxiety with or without school avoidance | 21 | Imipramine = placebo | |
| BZD | Bernstein et al, 1990 | School refusal and Separation Anxiety Disorder | 24 | Alprazolam = imipramine = placebo |
| Simeon et al, 1992 | Overanxious Disorder and Avoidant Disorder | 30 | Alprazolam = placebo | |
| Grae et al, 1994 | Separation Anxiety Disorder | 15 | Clonazepam = placebo | |
| α2 agonist | Strawn et al, 2017 | Mixed anxiety disorders | 83 | Guanfacine = placebo for PARS Guanfacine > placebo for CGI-I. |
Abbreviations: SSRI- Selective Serotonin Reuptake Inhibitor; SNRI- Serotonin Norepinephrine Reuptake Inhibitor; BZD- Benzodiazepine; TCA, tricyclic antidepressant; PARS, pediatric anxiety rating scale, CGI-I, clinical global impression-improvement; SoAD, social anxiety disorder; SET-C- Social Effectiveness Therapy for Children; CBT- Cognitive Behavioral Therapy; CGI-S- Clinical Global Impression-Severity Scale; ADHD- Attention Deficit Hyperactive Disorder; GAD – Generalized Anxiety Disorder